Regis Healthcare (REG) AGM 2024 summary

Opening remarks and agenda

• Chair welcomed attendees, acknowledged traditional landowners, and outlined meeting protocols, including voting and Q&A procedures.

• Agenda included Chair's address, CEO presentation, formal business, director elections, and closing remarks.

Financial performance review

• FY2024 revenue exceeded AUD 1,014.1 million (up 29.9%), underlying EBITDA reached AUD 107.2 million (up 28.7%), and NPATA was AUD 35.6 million (up 24.7%).

• Net cash position improved to AUD 64.9 million from net debt of AUD 6.0 million in FY23.

• Occupancy rose to 94.1% (spot occupancy 96% as of October 2024), outperforming sector averages.

• Share price increased 96.4% in FY2024, outperforming the ASX 300.

• Five-year CAGR for revenue and EBITDA were 8.4% and 7.9% respectively.

Board and executive committee updates

• Bryan Dorman, co-founder, retired from the board; Jodie Leonard joined as an independent director and Chair of the People and Remuneration Committee.

• Christine Bennett and Jodie Leonard stood for (re-)election, both supported unanimously by the board.